Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma.
Sho SekiyaJunki FukudaRyodai YamamuraTakako OoshioYusuke SatohShinya KosugeReo SatoKanako C HatanakaYutaka HatanakaTomoko MitsuhashiToru NakamuraYoshihiro MatsunoSatoshi HiranoMasahiro SonoshitaPublished in: Cancer research (2023)
Development of a Drosophila model mimicking genetic alterations in human pancreatic ductal adenocarcinoma provides a tool for genetic screening that identifies MEK and AURKB inhibition as a potential treatment strategy.